Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux

doi:10.3748/wjg.v12.i2.271

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2994)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

266

HTML

2352

Figures (1-5)

199

Tables (1-1)

177

Sum=2994

Jan 14, 2006 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jan 14, 2006; 12(2): 271-279
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.271

Full Size Figure Download Figure

Figure 3 Myeloperoxidase (MPO) activity in the esophageal mucosa 180 min after treatment. The plots demonstrate the median (horizontal line in the box), the 25^th (lower whisker) and 75^th (upper whisker) percentiles, respectively. ^aP < 0.05 between groups vs saline-treated control group values. ^cP < 0.05 between bile+7-NI-treated and bile+PC-treated groups vs bile-treated group values.

Citation: Eros G, Kaszaki J, Czobel M, Boros M. Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux. World J Gastroenterol 2006; 12(2): 271-279
URL: https://www.wjgnet.com/1007-9327/full/v12/i2/271.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i2.271